Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  De Luca, Maia ^a   Donà, Daniele ^b   Montagnani, Carlotta ^c   Vecchio, Andrea Lo ^d   Romanengo, Marta ^e   Tagliabue, Claudia ^f   Centenari, Chiara ^g   D'Argenio, Patrizia ^a   Lundin, Rebecca ^b   Giaquinto, Carlo ^b   Galli, Luisa ^c   Guarino, Alfredo ^d   Esposito, Susanna ^f   Sharland, Mike ^h   Versporten, Ann ⁱ   Goossens, Herman ⁱ   Nicolini, Giangiacomo ^j  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g Versilia Hospital   (Italy)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ UNIVERSITY OF ANTWERP   (Belgium)

^j SAN MARTINO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; ENZYME INHIBITOR; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIGECYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADOLESCENT; AGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BODY WEIGHT; BONE INFECTION; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FEVER; GASTROINTESTINAL INFECTION; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZED CHILD; HUMAN; INFANT; INFECTION; INFECTIOUS ARTHRITIS; ITALIAN (CITIZEN); LOWER RESPIRATORY TRACT INFECTION; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; OSTEOMYELITIS; PEDIATRICS; POINT PREVALENCE SURVEY; PRESCRIPTION; PREVALENCE; PYREXIA IDIOPATHICA; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT INDICATION; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; BACTERIAL INFECTIONS; CLINICAL TRIAL; COMBINATION DRUG THERAPY; HEALTH CARE SURVEY; HOSPITALIZATION; ITALY; MULTICENTER STUDY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGE FACTORS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; ITALY; TIME FACTORS;

EID: 84969542775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154662     Document Type: Article

References (49)

1. Van der Meer JW, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect. 2001; 7 Suppl 6:12-5. PMID: 11990686
2. CDC, Antibiotic Resistance Threats in the United States, 2013 available at www.cdc.gov/ drugresistance/pdf/ar-threats-2013-508.pdf
3. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003; 163(8):972-978. PMID: 12719208
4. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44(2):159-177. PMID: 17173212
5. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003; 36(11):1433-1437. PMID: 12766839
6. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009; 49(8):1175-1184. doi: 10.1086/605630 PMID: 19739972
7. Evans HL, Lefrak SN, Lyman J, Smith RL, Chong TW, McElearney ST et al. Cost of Gram-negative resistance. Crit Care Med. 2007; 35(1):89-95. PMID: 17110877
8. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(2):155-164. doi: 10.1086/524891 PMID: 18171244
9. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: The Centre; 2014.
10. Vaccheri A, Bjerrum L, Resi D, Bergman U, Montanaro N. Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen). J Antimicrob Chemother. 2002 Dec; 50(6):989-97. PMID: 12461022
11. Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient pediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol. 2007; 63:1099-1106. PMID: 17891535
12. Nicolini G, Donà D, Mion T, Barlotta A, Girotto S, Borgia E, et al. Use of amoxicillin, amoxicillin/clavulanate and cefaclor in the Italian pediatric population. Journal of Pediatric Infectious Diseases. vol. 9, no. 1, 2014, pp. 1-9.
13. Stam J, van Stuijvenberg M, Grüber C, Mosca F, Arslanoglu S, Chirico G, et al. Antibiotic use in infants in the first year of life in five European countries. Acta Paediatr. 2012 Sep; 101(9):929-34. doi: 10. 1111/j.1651-2227.2012.02728.x PMID: 22691104
14. Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML. Antibiotic treatments for children ages 0-23 months in a northern Italy region: a cohort study. Infection. 2006 Jun; 34(3):155-7. PMID: 16804659
15. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H; European Survaillance of Antibiotic Comsuption (ESAC) Project Group. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother. 2006 Jul; 58 (1):159-67. PMID: 16698845
16. Ciofi Degli Atti ML, Raponi M, Tozzi AE, Ciliento G, Ceradini J, Langiano T, et al. Point prevalence study of antibiotic use in a paediatric hospital in Italy. Euro Surveill. 2008 Oct 9; 13(41).
17. Buccellato E, Melis M, Biagi C, Donati M, Motola D, Vaccheri A. Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals. PLoS One. 2015 Sep 25; 10(9):e0139097. doi: 10.1371/journal.pone. 0139097 PMID: 26405817
18. Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H; ARPEC project group. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016 Jan 8.
19. Caffrey Osvald E, Prentice P. NICE clinical guideline: antibiotics for the prevention and treatment of early-onset neonatal infection. Arch Dis Child Educ Pract Ed. 2014 Jun; 99(3):98-100. doi: 10.1136/ archdischild-2013-304629 PMID: 24334339
20. Inglis GD, Jardine LA, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters. Cochrane Database Syst Rev. 2007 Oct 17;(4: ):CD004697. PMID: 17943827
21. Inglis GD, Jardine LA, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants. Cochrane Database Syst Rev. 2007 Jul 18;(3: ):CD004338. PMID: 17636752
22. Jardine LA, Inglis GD, Davies MW. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database Syst Rev. 2008 Jan 23;(1: ):CD006179. doi: 10.1002/14651858.CD006179.pub2 PMID: 18254094
23. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010 Nov 19; 59(RR-10):1-36. PMID: 21088663
24. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009 Jan; 123(1):58-66. doi: 10.1542/peds.2007-3423 PMID: 19117861
25. Hajdu A, Samodova OV, Carlsson TR, Voinova LV, Nazarenko SJ, Tjurikov AV, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect. 2007; 66(4):378-84. PMID: 17573155
26. Potocki M, Goette J, Szucs TD, Nadal D. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription. Infection. 2003; 31(6):398-403. PMID: 14735382
27. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013 Feb 1; 70(3):195-283. doi: 10.2146/ajhp120568 PMID: 23327981
28. Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.Cochrane Database Syst Rev. 2014 Oct 1; 10:CD005590. doi: 10. 1002/14651858.CD005590.pub3 PMID: 25269391
29. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am. 2004 Aug; 51(4):939-59, viii-ix. PMID: 15275982
30. Mtitimila EI, Cooke RW. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database Syst Rev. 2004 Oct 18;(4: ):CD004495. PMID: 15495114
31. Schulman J, Dimand RJ, Lee HC, Duenas GV, Bennett MV, Gould JB. Neonatal intensive care unit antibiotic use. Pediatrics. 2015 May; 135(5):826-33. doi: 10.1542/peds.2014-3409 PMID: 25896845
32. Patel SJ, Oshodi A, Prasad P, Delamora P, Larson E, Zaoutis T, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009; 28: 1047-51. doi: 10.1097/INF. 0b013e3181b12484 PMID: 19858773
33. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011 Oct; 53(7):617-30. doi: 10.1093/cid/cir625 PMID: 21890766
34. Sviestina I, Aston J, Lorrot M, Mozgis D. A comparison of antibiotic use in three specialist paediatric hospitals in France, Latvia and the UK. Eur J Hosp Pharm. 10/2014; 22(3).
35. Esposito S, Blasi F, Allegra L, Principi N; Mowgli Study Group. Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children. Eur J Clin Microbiol Infect Dis. 2001 Sep; 20(9):647-50. PMID: 11714047
36. Vaccheri A, Silvani MC, Bersaglia L, Motola D, Strahinja P, Vargiu A, et al. A 3 year survey on the use of antibacterial agents in five Italian hospitals. J Antimicrob Chemother. 2008 Apr; 61(4):953-8. doi: 10. 1093/jac/dkn010 PMID: 18218639
37. Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, et al. European Surveillance of Antibiotic Consumption (ESAC) point 528 prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 529 European countries. J Antimicrob Chemother. 2010; 65: 2247-52. doi: 10. 1093/jac/dkq309 PMID: 20713405
38. Lutsar I, Trafojer UM, Heath PT, Metsvaht T, Standing J, Esposito S, et al. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials. 2011 Sep 30; 12:215. doi: 10.1186/1745-6215-12-215 PMID: 21958494
39. Lietman PS. Fluoroquinolone toxicities. An update. Drugs. 1995; 49 Suppl 2:159-63. PMID: 8549287
40. Andriole VT. The quinolones: past, present, and future. Clin Infect Dis. 2005; 41 Suppl 2:S113-9. PMID: 15942877
41. Mills GD, Oehley MR, Arrol B. Effectiveness of b lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ. 2005; 330: 456-62. PMID: 15684024
42. Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics. 2006 Sep; 118 (3):1287-92. PMID: 16951028
43. Scottish Antimicrobial Prescribing Group (SAPG). Report on Antimicrobial Resistance and Use in Humans in 2008. Available: http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/ National-Medicines-UtilisationUnit/SAPG%20Report%20on%20Antimicrobial%20Resistance%20and %20Use%20in%20Humans%20in%202008.pdf
44. National Institute for Health and Care Excellence (NICE). Clostridium difficile infection: risk with broadspectrum antibiotics. Available: https://www.nice.org.uk/advice/esmpb1/resources/clostridium-difficileinfection-risk-withbroadspectrum-antibiotics-1502609568697285
45. Jenkins TC, Knepper BC, Sabel AL, Sarcone EE, Long JA, Haukoos JS, et al. Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess. Arch Intern Med. 2011 Jun 27; 171(12):1072-1079. doi: 10.1001/archinternmed.2011.29 PMID: 21357799
46. Dellit TH, Chan JD, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol. 2008 Jun; 29(6):525-533. doi: 10.1086/588160 PMID: 18510462
47. Viale P, Tumietto F, Giannella M, Bartoletti M, Tedeschi S, Ambretti S, et al. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy. Clin Microbiol Infect. 2015 Mar; 21(3):242-7. doi: 10.1016/j.cmi. 2014.10.020 PMID: 25658534
48. Pan A, Gagliotti C, Resi D, Moro ML. Antimicrobial stewardship programmes in Emilia-Romagna, Italy. Journal of Global Antimicrobial Resistance. 2013 Sep; 1(3):175-179.
49. Buone Pratiche per il controllo dell'antibiotico resistenza. Progetto CCM 2014. Available: http://www. ccm-network.it/imgs/C-27-MAIN-progetto-452-listaFile-List11-itemName-0-file.pdf